Experimental uric acid drug enters first human tests
NCT ID NCT06859073
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests an experimental drug called NNC4004-0002 in 60 adults with high uric acid but no symptoms. Participants receive either the drug or a placebo as a single injection under the skin. The main goal is to check safety and how the body handles the drug, with a secondary focus on its ability to lower uric acid levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NNC4004-0002 (an experimental drug given as an injection under the skin)
What this could lead to
If this drug is safe and lowers uric acid effectively, it could point toward a new treatment for high uric acid levels, potentially reducing the risk of gout or kidney stones.
What could go wrong
This is a very early (Phase 1) trial with only 60 people, so the drug may not work or could have side effects. It is the first time this drug is given to humans, so safety is still unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PAREXEL Glendale/LA EPCU
NOT_YET_RECRUITINGGlendale, California, 91206, United States
-
PAREXEL Intl - EPCU-Baltimore
RECRUITINGBaltimore, Maryland, 21225, United States